INTRODUCTION
interact with Brf1 and stimulate Pol III-dependent transcription (Gomez-Roman et al, 2003; 23 Marshall et al, 2012; Steiger et al, 2008) . Moreover, studies in both mammalian cells and Drosophila 24 suggest Ras signalling can regulate Myc levels and that Myc is required for Ras-induced 25 growth (Prober & Edgar, 2000; Prober & Edgar, 2002; Ren et al, 2013; Sears et al, 1999; Soucek et al, 26 2013). Indeed, we found that the UAS-EGFR-and UAS-Ras V12S35 -induced proliferation of larval AMPs 27 was blocked when we knocked down dMyc by expression of a UAS-dMyc RNAi construct 28 ( Supplementary Fig S3A-C) . We therefore examined whether dMyc functions downstream of Ras in 29 the control of Pol III. Using S2 cells we found that the increase in tRNA levels seen following Ras V12 30 expression was blocked when cells were treated with dsRNA to knockdown dMyc ( Fig 5A) . In 31 contrast we found that overexpression of dMyc in S2 cells was not able to induce tRNA synthesis in 32 cells in which the Ras pathway was inhibited by treatment with the MEK inhibitor UO126 ( Fig 5B) . 33 10 found that when we expressed UAS-dMaf1 RNAi in the Ras-responsive AMP cells during larval 11 development using esg-GAL4 ts , we observed a modest, but significant increase in the number of 12 AMP cells per cluster ( Supplementary Fig S4A) . Although considerably weaker than the effect of Ras 13 pathway activation, this effect of dMaf1 knockdown was similar to the increase in AMP numbers 14 seen with overexpression of dMyc, another stimulator of tRNA synthesis and mRNA translation 15 ( Supplementary Fig S4B) . We therefore next examined whether the Ras/ERK pathway functions to 16 promote tRNA synthesis by inhibiting dMaf1. We examined tRNA levels by Northern blot in S2 cells, 17 and, as described above, we saw that treatment of cells with the MEK inhibitor UO126 led to 18 reduced tRNA synthesis ( Fig 5C and 5D and Supplementary Fig S4) . However, we found that this 19 decrease in tRNA synthesis was reversed when cells were treated with dsRNA to knockdown dMaf1 20 levels ( Fig 5C and 5D and Supplementary Fig S4) . These data suggest that a main way that Ras/Erk 21 signalling functions to promote tRNA synthesis is by inhibiting the Pol III repressor function of 22 dMaf1. Studies in both yeast and mammals suggest that one way that dMaf1 can be regulated is by 23 controlling it's nuclear localization. We tested this in S2 cells using an antibody to endogenous 24 dMaf1. Under our normal media culture conditions, we observed that dMaf1 was localized 25 throughout the cell (Fig 5E and 5F ). However, treatment of cells with the MEK inhibitor U0126 26 leads to a significant increase in nuclear localization of dMaf1. Thus, Ras/ERK signalling functions 27 to prevent nuclear accumulation of dMaf1, hence blocking its Pol III repressor activity and 28 promoting tRNA synthesis. 
DISCUSSION

31
We propose that stimulation of RNA polymerase III and tRNA synthesis contributes to the ability of 32 the conserved Ras/ERK pathway to promotes mRNA translation and growth. Our data indicate that the main way Ras controls Pol III is by inhibiting the Maf1 repressor, in large part by preventing its 1 nuclear accumulation. Maf1 is a phospho protein and studies in yeast and mammalian cells have 2 described how phosphorylation can regulate Maf1 nuclear localization. For example, both TORC1 3 and PKA can phosphorylate on several conserved residues (Huber et al, 2009; Kantidakis et al, 4 2010; Michels et al, 2010; Moir et al, 2006; Shor et al, 2010; Wei et al, 2009 ). This phosphorylation 5 prevents Maf1 nuclear accumulation and allows both kinases to stimulate Pol III. In contrast, -either directly or indirectly -to prevent its function. Other mechanisms may also be important for 10 Ras to simulate tRNA synthesis. For example, one study in mammalian cells showed that ERK could 11 phosphorylate and regulate Brf1 function (Felton-Edkins et al, 2003) . Also Ras was shown to 12 upregulate TBP, which can increase transcription by all three RNA polymerases (Zhong et al, 2004) .
13
Importantly, Maf1 function is conserved suggesting that Ras/ERK-dependent regulation of Maf1 14 and tRNA synthesis that we describe in Drosophila may operate in other organisms, particularly 15 human cells.
17
We also show that the transcription factor Myc is required for the effects of Ras on Pol III and tRNA 18 synthesis. Previous work from both mammalian cells and Drosophila has shown that in some cells 19 Ras can promote Myc levels and that Ras-mediated growth requires Myc function (Prober & Edgar, 20 2000; Prober & Edgar, 2002; Ren et al, 2013; Sears et al, 1999; Soucek et al, 2013) . We previously 21 showed that Drosophila Myc could stimulate expression of the Pol III transcription factor, Brf1, and 22 also other Pol III subunits (Marshall et al, 2012) . In addition, Myc can directly interact with Brf1 and Previous studies in mammalian cells have shown that Ras/ERK signalling can promote protein 29 synthesis by stimulating translation initiation factor function. We suggest that inhibition of Maf1 30 represents another target of Ras/ERK signalling, and that the subsequent increase in tRNA levels Ras is one of the most often overactivated or mutated pathways in cancer, hence our findings may 10 also have implications for processes that contribute to tumour growth and metastasis. Indeed, there 11 is increasing appreciation for potential roles for alterations in tRNA biology in cancer cells (Grewal, 12 2015). For example, tRNA expression profiling has revealed that levels of many tRNAs are elevated 13 in different cancer types (Pavon-Eternod et al, 2009; Zhou et al, 2009 ). Interestingly, these changes 14 in tRNA levels have been shown to correlate with codon usage in mRNAs whose expression also 15 changes in cancer cells (Gingold et al, 2014) . Several studies have reported that increasing the 16 levels of specific tRNAs can promote tumour growth and metastatic behavior (Birch et al, 2016; Clarke et al, 2016; Goodarzi et al, 2016; Pavon-Eternod et al, 2013) . Previous work also showed that 18 increasing tRNA levels alone is sufficient to drive growth in Drosophila (Rideout et al, 2012; Rojas-19 Benitez et al, 2015). Hence, an increase in tRNA levels caused by oncogenic Ras signalling may be a 20 driver of tumour growth and progression, rather than simply a consequence of increased growth.
21
Ras also controls other process such as cell fate specification, differentiation and cell survival. Many 22 of these effects are mediated through translation and so may also rely on the effects of Ras on tRNA 23 synthesis. Flies were raised on standard medium (150 g agar, 1600 g cornmeal, 770 g Torula yeast, 675 g 29 sucrose, 2340 g D-glucose, 240 ml acid mixture (propionic acid/phosphoric acid) per 34 L water) and maintained at 25°C, unless otherwise indicated. The following fly stocks were used:
Puromycin-labelling protein synthesis assay 22 10 μM puromycin was added to Drosophila S2 cell culture media and the cells were incubated with 23 puromycin for 30 min at 25 °C. Cells were harvested by centrifugation at 4°C and washed with cold 24 PBS. Cells were frozen on dry ice and then lysed according to the Western blot protocol described In situ hybridization in wing imaginal discs 29 In situ hybridization analysis of tRNA iMet in wing discs was performed using digoxigenin-labelled 30 probes. The digoxigenin-labelled antisense riboprobe for tRNA iMet was synthesized by in vitro 31 transcription using Roche digoxigenin labeling kit. The tRNA iMet was amplified from either genomic 32 DNA or an expression plasmid containing the tRNA iMet gene. Primers used for the amplification are listed in Supplementary Table S1 . The in situ hybridizations were performed as described 1 previously (Grewal et al, 2007) . Briefly, inverted larvae were fixed in 4% paraformaldehyde (PFA), 2 permeablized and then hybridized with probe overnight at 55 °C (hybridization buffer contained 3 50% formamide, 5xSSC pH 6.2, 100 μg/ml salmon sperm DNA, 50 μg/ml heparin and 0.1% Tween 4 20). Probe binding was detected using anti-DIG-AP fab fragments (1:2000) in 1x PBTw and staining 5 with using 2% 4-nitroblue tetrazolium chloride (NBT), and 5-bromo-4-chloro-3-indolyl-phosphate 6 (BCIP) detection system (Roche). Total RNA was extracted from Drosophila S2 cells using TRIzol. 5 μg total RNA was separated on a 5 10 % denaturing polyacrylamide/urea gel and northern blotting was carried using alkaline transfer.
11
Hybridization of tRNA probes were carried out as described in Roche DIG Easy Hyb (Cat.
12
No.11603558001). Digoxigenin-labelled probes were made by in vitro transcription using either 13 full-length cDNAs or PCR fragments as templates.
15
Immunostaining 16 Drosophila S2 cells were fixed in 4% paraformaldehyde at room temperature for 20 mins on cover 17 slips. Wash with 1x PBS and permeabilized with 0.1% Triton X in PBS by washing 2x for 5 mins.
18
Cells were blocked with 5% FBS, 0.1% Triton X in PBS for 2 hours. Primary Maf1 antibody was 19 diluted in 5% BSA in PBS at 1:500 dilution and incubated overnight at 4 o C. Then washed 3x with 20 0.1% Triton X for 5 min each and Alexa 568 (Molecular probes) goat-anti rabbit secondary antibody 21 was diluted at 1:400 in 5% BSA in PBS for 2 hours at room temperature. Then, cells were washed 22 3x with 0.1 % Triton X in PBS for 5 min each and mounted using Vector Shield mounting medium. Figure 5 ) (A, B) UAS-dMaf1 RNAi (A) or UAS-dMyc (B) were expressed in AMPs using the esg-Gal4 ts system. Larvae were shifted to 29 o C at 24hrs of development and dissected at wandering stage. The numbers of cells in each AMP cluster were counted and expressed in box plots. (C) Maf1 mRNA levels were quantified by qRT-PCR data in cells treated with dsRNA to GFP (control) or dMaf1 (Maf1 RNAi) (D) Maf1 protein levels were measured by Western blot in cells treated with dsRNA to GFP (control) or dMaf1 (Maf1 RNAi). (E) dMaf1 was knocked down in Drosophila S2 cells by incubating cells with dsRNAs against Maf1. Control cells were treated with dsRNA to GFP. Cells were then treated with DMSO (control) or 10 µM U0126 for 2 hrs. Total RNA was isolated with Trizol and analyzed by Northern blot using DIG-labelled tRNA iMet probe. Ethidium bromide stained 5S rRNA band was used as a loading control. 
